Pneumocystis carinii is an important opportunistic pulmonary pathogen. The organism exists widely in nature as a saprophyte in the lungs of humans and a variety of animals; while isolates from these sources are morphologically identical, antigenic studies suggest that species and strain differences exist (9, 20, 34, 39) . Among humans, P. carinii causes pneumonia in premature, malnourished infants; children with primary immunodeficiency diseases (particularly severe combined immunodeficiency disease); patients receiving corticosteroids or other immunosuppressive drugs; and persons with the acquired immunodeficiency syndrome (AIDS) (26, 35) .
The specific host immune defects which predispose to the development of pneumocystosis are poorly understood. Animal challenge studies involving exogenous P. carinii have been severely hampered by the low virulence of the organism (2, 3, 27, 36) . Rats, mice, and other animals, when administered corticosteroids, spontaneously develop P. carinii pneumonia with histologic features closely resembling the human form of the disease by a process which involves reactivation of latent infection (3, 27-29, 37, 38, 46) . This model system has been widely used to study P. carinii but has not permitted direct analysis of the relationship between the organism and host immune function. Sporadic cases of pneumocystosis have been reported in aniamls with suspected or proven immunodeficiency disorders, and a few outbreaks of the disease have occurred in colonies of athymic (nude) mice (31, 32, 45) . Such "experiments of nature" provide unusual opportunities to study the epidemiology and pathogenesis of P. carinji pneumonia.
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The Cincinnati VA Medical Center has had a long-term interest in clinical and experimental P. carinii infection. Over the past several years we have had the opportunity to participate in the investigation of large outbreaks of pneumocystosis in colonies of immunodeficient mice at four different institutions. In the current study we present the clinical and pathological features of the disease, antigenic characteristics of the P. carinii isolates, host serologic responses, control measures, and the potential impact of these outbreaks on the use of immunodeficient mice in biomedical research. Investigators at each institution assumed primary responsibility for evaluating their own outbreak of pneumocystosis.
MATERIALS AND METHODS
Systematic steps were taken to define the clinical features of the illness, etiology, and extent of involvement of the animal population. Procedures included autopsies, histopathologic examination, cultures, and serologic studies. After documented cases of P. carinii pneumonia were found, one of us (P.D.W.) was contacted about further studies. The timing of this contact in relation to the stage of the outbreak had a major impact on the number of animal specimens available for investigation. In general, attempts were made to obtain fixed lung specimens for histologic examination, frozen lungs for immunofluorescence staining and immunoblotting analysis, and serum specimens for the determination of antibody titers to P. carinii.
Histopathology. Histopathologic examination of the lungs of the mice was performed by the veterinary pathologist at each institution. Specimens were also requested from the institutions so that the histologic features of pneumocystosis in the different outbreaks would be compared by a single pathologist (C.K.K.). Samples included already stained slides as well as frozen and fixed sections. Since freezing artifacts made detailed histologic examination difficult, the frozen lung sections were usually not included in the data analysis. To prepare permanent specimens, lung tissues were fixed in 4% buffered formaldehyde, embedded in paraffin, sectioned at 4 to 6 ,um, and stained with hematoxylin-eosin and Grocott methenamine silver stains. Specimens from 31 mice (11 nude and 20 scid mice) were examined in detail. The severity of pneumocystosis was graded using a previously described scoring system (19, 37, 38) with minor modification: light infection (<25% alveoli involved); moderate infection (25 to 50% alveoli involved); heavy infection (>50% alveoli involved).
Immunofluorescence. Immunofluorescence studies were performed on infected lungs in an attempt to determine the source of the outbreaks (i.e., whether the P. carinii organisms were of mouse, rat, or human origin). Lung specimens sent to us in the early stages of the study varied considerably in the quality and quantity of material, storage conditions, method of preparation, and intensity of P. carinii infection. Later, a more uniform protocol was devised in which investigators usually sacrificed the mice, removed and froze the lungs, and shipped them to us on dry ice; in a few instances, live mice were shipped directly to us to provide fresh lungs.
The lung samples were studied by an indirect fluorescentantibody (IFA) technique as described previously (39, 40, 42) , with slight alteration. Specimens were prepared for analysis either as frozen sections or as a preparation homogenized in a Stomacher (Tekmar, Inc., Cincinnati, Ohio), added to the wells of a glass slide, air dried, and heat or acetone fixed. Lung specimens from immunosuppressed normal mice, rats, and humans with documented P. carinji pneumonia, prepared in a similar manner, served as positive controls. The presence of P. carinii was documented in frozen sections by methenamine silver stains and in lung homogenates by the cresyl echt violet stain.
Reagents used in the IFA technique were prepared according to procedures outlined in earlier studies (25, 34, 41 Immunoblotting. Immunoblotting studies were performed by procedures described in detail in earlier reports (34, 44 carinii were used as antigen or when Tris-buffered saline was substituted for the primary antibody.
RESULTS
Clinical features of the outbreaks. (i) University of Michigan. One outbreak occurred in a colony of 100 Crl:CDI (ICR) nulnu mice maintained under microbiologic barrier conditions at the University of Michigan. The mice were all obtained from the same commercial vendor and were grouphoused on autoclaved corn cob bedding in 22 plastic shoebox cages with filter tops. They were provided autoclaved commercial rodent chow and water ad libitum. The cages were distributed among two positive-pressure, laminar flow, mass air displacement racks within a room that was designated solely for housing nude mice. The animals were used experimentally to carry human squamous cell carcinoma cells or human breast cancer cells, but the majority of the animals in the colony were not implanted with tumors.
P. carinii was first detected histopathologically in 12 of 16 clinically healthy, 4-to 5-month-old outbred nude mice at the routine termination of a cancer chemotherapy research project. Four months later, wasting and occasional spontaneous deaths of 5-to 7-month-old nude mice belonging to the other investigators in the room began to occur. In addition to weight loss, clinical signs in some animals included cyanosis and dyspnea. Eight moribund nude mice from the total population representing all investigators were humanely euthanized and necropsied. Microscopic lesions were limited to the lung and showed typical features of pneumocystosis.
Anal tapes and fecal direct smears were negative for parasites. Serology for Mycoplasma pulmonis and 11 major murine viruses, including Sendai virus, mouse hepatitis virus, pneumonia virus of mice, and polyomavirus, was performed (Charles River Biotechnical Services, Inc.). Three clinically ill nulnu mice aged 6 to 7 months were seronegative on all 12 tests. Ten nul+ mice housed with the nude mice and which served as sentinel animals were serologically negative for antibodies in the test panel.
P. carinii pneumonia was eliminated from the animal facility at the University of Michigan by quarantine and depopulation of the entire nude mouse colony and repopulation with animals free of the organism.
(ii) Fox Chase Cancer Center. The Fox Chase Cancer
Center outbreak in C B-17/Icr scidlscid mice was first recognized in mid 1984 as an increase in mortality within a colony of approximately 900 scidlscid mice. All of these mice were housed in microisolator cages within the conventional rodent colony. Necropsies on about 100 animals were performed over the next 9 months (August, 1984, to April, 1985) . Of these, 66 animals were diagnosed as positive for P.
carinii with methenamine silver stain. The age of affected animals ranged from 17 through 87 weeks, with the majority between 35 and 40 weeks. Clinically, the animals presented with chronic debilitation, weight loss, and dyspnea which progressed to cyanosis. The mice were frequently ill for several months before they became moribund. The lungs were densely consolidated with a firm, rubber consistency and did not "deflate" when the thoracic cavity was opened. The colony was euthanized and repopulated with animals from a barrier colony which had always been free of P. carinii infection as judged by histologic examination. These mice have remained in good health. Since trimethoprim-sulfamethoxazole (TMP-SMZ) suspension had been previously shown to be effective in the prevention and treatment of P. carinii pneumonia in humans and in corticosteroid-suppressed rats (15) (16) (17) , scidlscid mice were placed on a regimen of TMP-SMZ in the drinking water. To assess the efficacy of TMP-SMZ treatment in a conventional mouse room environment, breeding pairs of scid/scid mice were removed from the PIV rack and placed in conventional mouse boxes. A dose of 500 of SMZ and 100 mg of TMP per kg per day was supplied in the drinking water as Sulfatrim suspension (Goldline Laboratories). The mice were supplied with TMP-SMZ suspension in drinking water for 3 days per week and were provided with water alone for the remainder of the week in a manner similar to the intermittent chemoprophylactic regimen used in rats (18) .
Treatment with TMP-SMZ had a remarkable effect on the health of the scid/scid mice, with improvement in their overall appearance and an increase in their life span. The first scid/scid mice were started on the TMP-SMZ regimen shortly after birth and have been followed for 6 months; the overall mortality has been <5%. Five of these animals were killed at 3 to 4 months of age, and histopathological evaluation of methenamine silver-stained lung sections revealed widely scattered P. carinii organisms with focal accumulations of macrophages. Moreover, the breeding performance of homozygotes did not appear to be affected by the TMP-SMZ therapy. New generations of mice are currently being derived by hysterectomy. On the other hand, six young scidl scid mice were first placed in the PIV rack for 6 weeks and then begun on TMP-SMZ; analysis of the lungs of these animals killed at 6 to 7 months of age revealed severe P. carinii pneumonia.
Histopathology. The histologic features of the different outbreaks of pneumocystosis were very similar, although the extent of disease varied among individual mice. Of the 11 nude mice graded by a single examiner, 3 had light, 5 had moderate, and 3 had severe P. carinii pneumonia; of 20 scid mice analyzed, 5 had light, 4 had moderate, and 11 had severe disease.
Representative histologic features of pneumocystosis are presented in Figure 1 . In light infection, the underlying lung architecture was not altered except for slight interstitial thickening and mild chronic inflammatory cell infiltrates. Methenamine silver stain depicted P. carinii cyst forms along the alveolar walls. As the disease progressed, the alveolar lumens contained the characteristic foamy honeycomb material (Fig. 1A to C) which revealed various numbers of organisms (Fig. 1D) . In some areas, the alveoli contained prominent collections of macrophages but few P.
carinii organisms (Fig. 1E and F) . Severe pneumocystosis was characterized by extensive alveolar filling with the foamy material and masses of P. carinii, interstitial thickening with edema and mild fibrosis, and foci of atelectasis with compensatory hyperinflation; however, host inflammatory cell infiltrates were still rather inconspicuous.
Immunofluorescence. Initial IFA studies were performed on nulnu mice obtained from the University of Michigan and on scidlscid mice obtained from Fox Chase. Since we were contacted late in the course of these outbreaks, we were only able to obtain four mice (two nude, two scid) with sufficient lung tissue and P. carinii infection available for testing. All specimens reacted with pooled mouse serum, suggesting a mouse strain of organism. However, discrepancies (e.g., variation in the intensity of the immunofluorescent staining) occurred between lung homogenates and frozen sections when tested with rabbit antisera to rat and human P. carinii, thus making further data interpretation difficult.
The outbreak at Smith Kline & French provided a larger number of mice to study as well as the opportunity to develop a more uniform protocol. Lung homogenates were chosen as the standard antigen preparation because the immunofluorescent staining was consistently easier to interpret than were the frozen sections. Specimens from all nine nulnu mice examined reacted with pooled mouse serum, rabbit antisera to rat P. carinii, and rabbit antisera to human P. carinii by IFA. In contrast, no lung homogenates from six nul+ mice reacted with any source of antibody.
The results of serologic testing in 22 mice by IFA are presented in Fig. 2 . Serum antibodies to mouse P. carinii were detected in 10 of 12 nul+ mice housed in the same room as the nulnu mice; 6 of these animals had a reciprocal titer of >8. Serum antibodies to rat P. carinii were detected in only four of the nul+ mice, and the titers were lower than those to mouse P. carinii. No antibodies to human P. carinfi were detected. Only 1 of 10 nulnu mice had detectable serum antibodies to any source of P. carinii, and this was a low titer of antibodies to mouse-derived organisms.
When we heard about the problem of pneumocystosis in the nude mouse colony at Fox Chase, we obtained lung specimens from five nulnu mice. The lung homogenates from four of these animals had P. carinii by cresyl echt violet stain; all of these specimens reacted with pooled mouse serum as well as with rabbit antisera to rat and human P. carinii by IFA.
Serum antibodies to P. carinii were measured among nul nu and nul+ mice; because of the small amounts of serum available, specimens from one to three animals were pooled for analysis. All three serum specimens from the nul+ mice had reciprocal antibody titers of 128 (Fig. 2) . Only one of these mice had antibodies to rat P. carinfii, and none had antibodies to human organisms. No serum antibodies to any source of P. carinii were found in two specimens from nulnu mice.
Eight scid/scid mice were obtained from the Research Animal Facility at The Jackson Laboratory for analysis. The animals had been housed for 3 to 5 months and appeared clinically ill. The lung homogenates from all eight scid/scid mice reacted with pooled mouse serum and rabbit antisera to rat and human P. carinii by IFA.
Immunoblotting. In the immunoblotting studies, lung homogenates from mice in the different outbreaks were probed with different sources of antibody and compared with the antigenic profile of rat and human P. carinii. Data obtained using rabbit antiserum to rat P. carinii are presented in Fig.  3 . As in our earlier reports (34) , multiple bands were found with rat P. carinii, the most prominent of which were moieties of about 45, 50, and 116 kilodaltons (kDa) (Fig. 3,   lane 8) . The principal antigen recognized in human P. carinui was a broad-based band of about 40 kDa (lane 9). The major antigens recognized in mouse P. carinii were bands of about 45 and 50 kDa, as seen in specimens from Fox Chase (lanes 2 and 3), Smith Kline (lanes 4 and 5), and Jackson Laboratory (lanes 6 and 7); these moieties were similar to the 45- and 50-kDa bands seen in rat P. carinii. Other bands (e.g., 92-kDa moiety) that were consistently found in P. carinfii from mice also appeared to be present in rat P. carinii. However, low-molecular-weight antigens detected in P. carinii of Smith Kline mice (Fig. 3, lanes 4 and 5) were present only weakly or not at all in specimens of other animals. No immunoreactivity was found in lung homogenate from a Smith Kline mouse without P. carinii infection (lane 1).
The results obtained using rabbit antiserum to human P. carinii as the source of antibody are presented in Fig. 4 . As noted in our previous studies (34) , the antiserum detected the broad-based 40-kDa antigen in human P. carinfii as well as less prominent bands of about 66 and 116 kDa (Fig. 4, lane  9) . The antiserum reacted with the 45-and 50-kDa antigens along with other moieties in rat P. carinfii (lane 8), but the 116-kDa band was not detected. Mouse P. carinii specimens from Smith Kline (Fig. 4, lanes 4 and 5) , Fox Chase (lanes 2 and 3), and Jackson Laboratory (lanes 6 and 7) all demonstrated bands of 45 and 50 kDa of varying intensity; immunoreactive moieties of other molecular masses (e.g., 92 kDa) were also detected in most of the mouse P. carinii specimens. No bands were found in the mouse lung without P. carinii (Fig. 4, lane 1) .
Probing the specimens with pooled mouse serum as the source of antibody revealed a different pattern of antigen recognition (Fig. 5) . As in the immunofluorescence experiments, there was no reactivity with rat P. carinii (lane 8) or human P. carinii (lane 9). All six mouse P. carinii lungs (lanes 2 through 7) demonstrated at least one band of varying intensity of about 50 kDa; a doublet was found in specimens from Smith Kline (lanes 4 and 5). The mouse serum also reacted with a band of 116 kDa in P. carinii specimens from Fox Chase (lanes 2 and 3) and the Jackson Laboratory (lanes 6 and 7); this antigen was very similar to the 116-kDa moiety in rat and human P. carinii recognized by the rabbit antisera. In contrast, the 116-kDa antigen was not recognized in P. carinii of five Smith Kline mice: two specimens presented here (Fig. 5, lanes 4 and 5) and three specimens analyzed separately (data not shown). No immunoreactivity occurred with mouse lung homogenate without P. carinii (Fig. 5 , lane 1). 
DISCUSSION
This study has described outbreaks of pneumocystosis in two types of immunodeficient mice at four different institutions. The clinical features of the disease were similar in each outbreak and also resembled those found in previous reports (31, 45) . P. carinii pneumonia presented as a subacute or chronic illness, lasting weeks to months and characterized by wasting, debilitation, and respiratory distress. Older mice were more severely affected than were younger mice. On histopathologic examination, the alveoli showed the typical foamy eosinophilic material, but the host inflammatory response was mild and nonspecific. These features are similar to those found in previous studies of P. carinii pneumonia in nude mice and in corticosteroid-treated normal mice and rats (37, 38, 43 (39, 41) . Rats exposed to rat P. carinii developed serum antibodies to both rat and mouse organisms, whereas mice exposed to mouse or rat P. carinii developed serum antibodies to each source of organisms with little or no cross-reactivity. Pooled mouse serum specimens used in the present study exhibited a similar immunoreactive pattern and were thus interpreted as reasonably specific for mouse P. carinii.
All infected lung homogenates from immunodeficient mice in the present study reacted with pooled mouse serum by IFA, suggesting the organisms were derived from mice. It was not possible to distinguish among individual P. carinii isolates in these outbreaks because they all reacted with rabbit antisera to rat and human P. carinii and exhibited a similar immunofluorescent staining pattern. Monoclonal antibodies might be helpful in analyzing species differences in P. carinii (8, 9, 21, 23, 24) ; yet, since these reagents have Serum antibody results indicated that the principal serologic response of nul+ mice at Smith Kline and Fox Chase was directed towards mouse P. carinii, thus lending further support to the hypothesis that mouse-derived organisms were the cause of illness in these outbreaks. As in our previous studies (41) , nude mice were unable to mount a meaningful antibody response to any source of P. carinii.
In recent years, immunoblotting has been used to compare the antigenic characteristics of rat and human P. carinii (8-10, 20, 23, 34) . The present study has applied this technique to mouse P. carinii, and overall, the data are consistent with the results obtained with immunofluorescence. Rabbit antisera to rat and human P. carinii reacted with bands of 45 kDa, 50 kDa, and other molecular masses in infected-lung homogenates of three different groups of mice, suggesting shared or cross-reacting determinants. The antigenic characteristics of mouse P. carinii appear to be more closely related to those of rat than to those of human P. carinii. The specificity of the pooled mouse serum for mouse P. carinii was again demonstrated by its lack of reactivity with rat-or human-derived organisms. This serum did react with a 116-kDa band and other moieties in infected mouse lungs. The 116-kDa antigen in mouse P. carinii is very similar to the 116-kDa bands in rat and human P. carinii. It is of interest that, when tested with different reagents in this study, these antigens only reacted with the homologous source of antibody. Whether the differences in immunoreactivity among the Smith Kline & French nulnu mice represent true species or strain differences in P. carinii, or perhaps are merely due to technical factors, is unclear; however, all lung specimens were prepared and analyzed in a similar manner.
Introduction of P. carinii into a colony of immunodeficient mice may be related to the manner in which these animals are obtained. Nude mice at the University of Michigan and Smith Kline & French were purchased from the same commercial vendor. This breeder had been implicated as the source of a previously reported outbreak of pneumocystosis in nulnu mice (45) , and conversations among veterinarians revealed that several additional institutions were experiencing problems with P. carinii among nude mice obtained from this company. Investigations by the vendor indicated that P. carinii was present among mice in certain breeding facilities but not in others. This information is important not only for researchers but also because it can enable a vendor to adjust breeding activities to ensure an adequate supply of mice free of P. carinii infection.
Although the scidlscid mice at The Jackson Laboratory were originally developed from breeding pairs of animals obtained from Fox Chase, the source of the pneumocystis outbreaks at these two institutions could not be determined. Once P. carinii became established at The Jackson Laboratory, the organism apparently spread to other mice as the colony expanded. The fact that P. carinii may be present in research colonies of scidlscid or nulnu mice has important implications for investigators who wish to develop colonies of these immunodeficient animals at their own institutions.
The spread of pneumocystosis among the animal colonies described in the present study emphasizes the communicability of the organism. Previous reports have implicated the airborne route as the mode of transmission (11, 13, 14, 43) (43) . In later studies performed at another institution with a different strain of nude mice and with nude rats, we were unable to achieve the experimental transmission of P. carinii with any degree of consistency (36 (15) (16) (17) (18) , there has been reluctance to use these agents in immunodeficient mice. These drugs are not microbicidal for P. carinii and hence are only effective in chemoprophylaxis as long as they are being given (12) . Since TMP-SMZ and related drugs work by inhibiting synthesis of folic acid, there has been concern about their effects on animal breeding, immune function, or use in tumor studies. The apparent success of TMP-SMZ on the scidlscid mice in a conventionally housed research colony at The Jackson Laboratory is encouraging. Since P. carinii organisms could still be found in healthy animals, further studies will be necessary to find the optimal dose regimen.
Outbreaks of pneumocystosis constitute a major problem to colonies of immunodeficient mice and may be becoming more common. Successful strategies to meet this challenge should include strictly controlled policies for breeding and maintaining these colonies, careful surveillance for P. carinii, and early intervention at the first signs of infection. The only available method for detecting P. carinii in mouse colonies has been lung histology, which is cumbersome, time consuming, expensive, and relatively insensitive. The present study has demonstrated the feasibility of using serology as a sensitive test to monitor sentinel heterozygote mice for exposure to P. carinii in a manner similar to that used for viruses and mycoplasma. The major impediment to INFECT. IMMUN. on August 27, 2017 by guest http://iai.asm.org/ Downloaded from the use of serology is a lack of a ready supply of antigen. Moreover, serological tests cannot be used to diagnose pneumocystosis in immunodeficient mice since some of these animals lack immunoglobulins or are poor antibody responders. Systems for detecting P. carinii antigens or genetic material in tissues might be explored as alternative diagnostic techniques (33) . Regardless of the method used, the heightened interest in P. carinii and widespread use of immunodeficient mice in biomedical research emphasize the need to develop practical methods of detecting and controlling infection with the organism in these animal colonies.
